Charles Schwab Investment Management Inc Kura Oncology, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 598,724 shares of KURA stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
598,724
Previous 579,987
3.23%
Holding current value
$12.3 Million
Previous $8.34 Million
53.12%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding KURA
# of Institutions
174Shares Held
80.4MCall Options Held
914KPut Options Held
120K-
Suvretta Capital Management, LLC New York, NY7.07MShares$146 Million6.46% of portfolio
-
Black Rock Inc. New York, NY6.9MShares$142 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$120 Million3.53% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$111 Million2.38% of portfolio
-
Bvf Inc San Francisco, CA4.79MShares$98.6 Million3.06% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.38B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...